PURIFICATION OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FROM THE INCLUSION-BODIES PRODUCED BY TRANSFORMED ESCHERICHIA-COLI-CELLS

被引:28
|
作者
BELEW, M
ZHOU, Y
WANG, S
NYSTROM, LE
JANSON, JC
机构
[1] CHINESE ACAD PREVENT MED,INST VIROL,NATL LAB MOLEC BIOL & GENET ENGN,BEIJING 100052,PEOPLES R CHINA
[2] N CHINA PHARMACEUT CORP,INST ANTIBIOT,HEBEI,PEOPLES R CHINA
关键词
D O I
10.1016/0021-9673(94)80312-9
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF), produced as inclusion bodies in genetically transformed Escherichia coli cells was purified to homogeneity by a three-step chromatographic procedure involving hydrophobic interaction, ion exchange and gel filtration. Each purification step is reproducible and well suited for process-scale operations. The purification process also leads to a significant decrease in DNA and endotoxin levels in the final product. Of the three gel media used, Phenyl Sepharose 6 FF (high sub) was most effective in reducing the DNA content (by a factor of ca. 2000) while Superdex 75 prep grade was more effective for removing endotoxins (reduction factor ca. 15). The recovery of purified rhGM-CSF was 35% by enzyme-linked immunosorbent assay and 70% by a biological assay method. The overall purification factor obtained was about 4.6, which is in the range of those reported for recombinant proteins produced in E. coli as inclusion bodies. The purified rhGM-CSF is an acidic protein (pI = 5.4) and has a specific activity of ca. 3.3.10(7) units/mg, which is in excellent agreement with that reported for its natural counterpart. Its monomer molecular mass of 14 605, as determined by electrospray mass spectrometry, corresponds exactly to the mass calculated from its cDNA sequence. Its amino acid composition and partial NH2-terminal sequence (up to seventeen residues) are also identical with those reported for this protein. These and other results confirm the identity of the purified rhGM-CSF with its natural counterpart. However, the results also showed that it is apparently heterogeneous from its NH2-terminal side as it is composed of three polypeptides having Met, Ala and Pro as the NH2-terminal residues in which the intact Met analogue accounts for 60% for the mixture. This heterogeneity does not seem to have any biological significance since the specific activity of the purified rhGM-CSF is identical with that of its natural counterpart.
引用
收藏
页码:67 / 83
页数:17
相关论文
共 50 条
  • [41] MOLECULAR MODELING OF HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
    KAUSHANSKY, K
    BROWN, CB
    OHARA, PJ
    INTERNATIONAL JOURNAL OF CELL CLONING, 1990, 8 : 26 - 34
  • [42] Recombinant human granulocyte-macrophage colony-stimulating factor: effect of glycosylation on pharmacokinetic parameters
    Marini, Guillermo
    Forno, Guillermina
    Kratje, Ricardo
    Etcheverrigaray, Marina
    ELECTRONIC JOURNAL OF BIOTECHNOLOGY, 2007, 10 (02) : 271 - 278
  • [43] Efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte macrophage colony-stimulating factor in neutropenic children with malignancies
    Lydaki, E
    Bolonaki, E
    Stiakaki, E
    Dimitriou, H
    Kambourakis, A
    Kalmantis, T
    Kalmanti, M
    BLOOD, 1995, 86 (10) : 2785 - 2785
  • [44] REGULATION OF EXPRESSION OF HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
    CHAN, JY
    SLAMON, DJ
    NIMER, SD
    GOLDE, DW
    GASSON, JC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (22) : 8669 - 8673
  • [45] NMR assignment of human granulocyte-macrophage colony-stimulating factor
    Sauve, Simon
    Gingras, Genevieve
    Aubin, Yves
    BIOMOLECULAR NMR ASSIGNMENTS, 2008, 2 (01) : 5 - 7
  • [46] The effects of recombinant granulocyte-macrophage colony-stimulating factor on the capacity of mononuclear cells from preterm infants to generate interleukin 6 and granulocyte colony-stimulating factor
    Li, Y
    Ohls, RK
    Christensen, RD
    INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, 1996, 3 (01): : 63 - 67
  • [47] EXPRESSION OF HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GENE IN INSECT CELLS
    SHI, XQ
    QIN, JC
    ZHU, J
    ZHU, DX
    MI, YD
    WU, XF
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 1995, 27 (05): : 559 - 564
  • [48] LEVELS OF HUMAN SERUM GRANULOCYTE COLONY-STIMULATING FACTOR AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR UNDER PATHOLOGICAL CONDITIONS
    OMORI, F
    OKAMURA, S
    SHIMODA, K
    OTSUKA, T
    HARADA, M
    NIHO, Y
    BIOTHERAPY, 1992, 4 (02) : 147 - 153
  • [49] EFFECT OF HUMAN RECOMBINANT GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR AND NATIVE GRANULOCYTE COLONY-STIMULATING FACTOR ON CLONOGENIC LEUKEMIC BLAST CELLS
    ASANO, Y
    SHIBUYA, T
    OKAMURA, S
    YAMAGA, S
    OTSUKA, T
    NIHO, Y
    CANCER RESEARCH, 1987, 47 (21) : 5647 - 5648
  • [50] Renaturation of recombinant human granulocyte colony-stimulating factor produced from Escherichia coli using size exclusion chromatography
    Wang, CZ
    Wang, LL
    Geng, XD
    JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2006, 29 (02) : 203 - 217